ヒト注射インフルエンザワクチンのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Human Injection Flu Vaccine Market Insights, Forecast to 2028

• レポートコード：QY2207E10374 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のヒト注射インフルエンザワクチンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にヒト注射インフルエンザワクチンの世界市場のxxx％を占める「三価インフルエンザワクチン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「6ヶ月～3年」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のヒト注射インフルエンザワクチンの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのヒト注射インフルエンザワクチン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのヒト注射インフルエンザワクチン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ヒト注射インフルエンザワクチンのグローバル主要メーカーには、Sanofi、CSL、GSK、Viatris、AstraZeneca、Hualan Bio、Changchun Institute of Biological、Sinovac、Jiangsu GDK、KM Biologicsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ヒト注射インフルエンザワクチン市場は、種類と用途によって区分されます。世界のヒト注射インフルエンザワクチン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 三価インフルエンザワクチン、四価インフルエンザワクチン 【用途別セグメント】 6ヶ月～3年、>3年 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ヒト注射インフルエンザワクチン製品概要 - 種類別市場（三価インフルエンザワクチン、四価インフルエンザワクチン） - 用途別市場（6ヶ月～3年、>3年） - 調査の目的 ・エグゼクティブサマリー - 世界のヒト注射インフルエンザワクチン販売量予測2017-2028 - 世界のヒト注射インフルエンザワクチン売上予測2017-2028 - ヒト注射インフルエンザワクチンの地域別販売量 - ヒト注射インフルエンザワクチンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ヒト注射インフルエンザワクチン販売量 - 主要メーカー別ヒト注射インフルエンザワクチン売上 - 主要メーカー別ヒト注射インフルエンザワクチン価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（三価インフルエンザワクチン、四価インフルエンザワクチン） - ヒト注射インフルエンザワクチンの種類別販売量 - ヒト注射インフルエンザワクチンの種類別売上 - ヒト注射インフルエンザワクチンの種類別価格 ・用途別市場規模（6ヶ月～3年、>3年） - ヒト注射インフルエンザワクチンの用途別販売量 - ヒト注射インフルエンザワクチンの用途別売上 - ヒト注射インフルエンザワクチンの用途別価格 ・北米市場 - 北米のヒト注射インフルエンザワクチン市場規模（種類別、用途別） - 主要国別のヒト注射インフルエンザワクチン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのヒト注射インフルエンザワクチン市場規模（種類別、用途別） - 主要国別のヒト注射インフルエンザワクチン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のヒト注射インフルエンザワクチン市場規模（種類別、用途別） - 主要国別のヒト注射インフルエンザワクチン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のヒト注射インフルエンザワクチン市場規模（種類別、用途別） - 主要国別のヒト注射インフルエンザワクチン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのヒト注射インフルエンザワクチン市場規模（種類別、用途別） - 主要国別のヒト注射インフルエンザワクチン市場規模（トルコ、サウジアラビア） ・企業情報 Sanofi、CSL、GSK、Viatris、AstraZeneca、Hualan Bio、Changchun Institute of Biological、Sinovac、Jiangsu GDK、KM Biologics ・産業チェーン及び販売チャネル分析 - ヒト注射インフルエンザワクチンの産業チェーン分析 - ヒト注射インフルエンザワクチンの原材料 - ヒト注射インフルエンザワクチンの生産プロセス - ヒト注射インフルエンザワクチンの販売及びマーケティング - ヒト注射インフルエンザワクチンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ヒト注射インフルエンザワクチンの産業動向 - ヒト注射インフルエンザワクチンのマーケットドライバー - ヒト注射インフルエンザワクチンの課題 - ヒト注射インフルエンザワクチンの阻害要因 ・主な調査結果

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Market Analysis and Insights: Global Human Injection Flu Vaccine Market
Due to the COVID-19 pandemic, the global Human Injection Flu Vaccine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Trivalent Influenza Vaccine accounting for % of the Human Injection Flu Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While 6 Months to 3 Years segment is altered to an % CAGR throughout this forecast period.
China Human Injection Flu Vaccine market size is valued at US$ million in 2021, while the US and Europe Human Injection Flu Vaccine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Human Injection Flu Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Human Injection Flu Vaccine include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and Jiangsu GDK and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Human Injection Flu Vaccine Scope and Segment
Human Injection Flu Vaccine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Human Injection Flu Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application
6 Months to 3 Years
> 3 Years
By Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Human Injection Flu Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Human Injection Flu Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market by Application
1.3.1 Global Human Injection Flu Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Injection Flu Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Human Injection Flu Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Human Injection Flu Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Human Injection Flu Vaccine Sales by Region
2.4.1 Global Human Injection Flu Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Human Injection Flu Vaccine by Region (2023-2028)
2.5 Global Human Injection Flu Vaccine Revenue by Region
2.5.1 Global Human Injection Flu Vaccine Revenue by Region (2017-2022)
2.5.2 Global Human Injection Flu Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Injection Flu Vaccine Sales by Manufacturers
3.1.1 Global Top Human Injection Flu Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Human Injection Flu Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Injection Flu Vaccine in 2021
3.2 Global Human Injection Flu Vaccine Revenue by Manufacturers
3.2.1 Global Human Injection Flu Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Human Injection Flu Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Human Injection Flu Vaccine Revenue in 2021
3.3 Global Human Injection Flu Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Injection Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Injection Flu Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Injection Flu Vaccine Sales by Type
4.1.1 Global Human Injection Flu Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Human Injection Flu Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Human Injection Flu Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Human Injection Flu Vaccine Revenue by Type
4.2.1 Global Human Injection Flu Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Human Injection Flu Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Human Injection Flu Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Human Injection Flu Vaccine Price by Type
4.3.1 Global Human Injection Flu Vaccine Price by Type (2017-2022)
4.3.2 Global Human Injection Flu Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Human Injection Flu Vaccine Sales by Application
5.1.1 Global Human Injection Flu Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Human Injection Flu Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Human Injection Flu Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Human Injection Flu Vaccine Revenue by Application
5.2.1 Global Human Injection Flu Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Human Injection Flu Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Human Injection Flu Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Human Injection Flu Vaccine Price by Application
5.3.1 Global Human Injection Flu Vaccine Price by Application (2017-2022)
5.3.2 Global Human Injection Flu Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Human Injection Flu Vaccine Market Size by Type
6.1.1 North America Human Injection Flu Vaccine Sales by Type (2017-2028)
6.1.2 North America Human Injection Flu Vaccine Revenue by Type (2017-2028)
6.2 North America Human Injection Flu Vaccine Market Size by Application
6.2.1 North America Human Injection Flu Vaccine Sales by Application (2017-2028)
6.2.2 North America Human Injection Flu Vaccine Revenue by Application (2017-2028)
6.3 North America Human Injection Flu Vaccine Market Size by Country
6.3.1 North America Human Injection Flu Vaccine Sales by Country (2017-2028)
6.3.2 North America Human Injection Flu Vaccine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Human Injection Flu Vaccine Market Size by Type
7.1.1 Europe Human Injection Flu Vaccine Sales by Type (2017-2028)
7.1.2 Europe Human Injection Flu Vaccine Revenue by Type (2017-2028)
7.2 Europe Human Injection Flu Vaccine Market Size by Application
7.2.1 Europe Human Injection Flu Vaccine Sales by Application (2017-2028)
7.2.2 Europe Human Injection Flu Vaccine Revenue by Application (2017-2028)
7.3 Europe Human Injection Flu Vaccine Market Size by Country
7.3.1 Europe Human Injection Flu Vaccine Sales by Country (2017-2028)
7.3.2 Europe Human Injection Flu Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Injection Flu Vaccine Market Size by Type
8.1.1 Asia Pacific Human Injection Flu Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Human Injection Flu Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Human Injection Flu Vaccine Market Size by Application
8.2.1 Asia Pacific Human Injection Flu Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Human Injection Flu Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Human Injection Flu Vaccine Market Size by Region
8.3.1 Asia Pacific Human Injection Flu Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Human Injection Flu Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Human Injection Flu Vaccine Market Size by Type
9.1.1 Latin America Human Injection Flu Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Human Injection Flu Vaccine Revenue by Type (2017-2028)
9.2 Latin America Human Injection Flu Vaccine Market Size by Application
9.2.1 Latin America Human Injection Flu Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Human Injection Flu Vaccine Revenue by Application (2017-2028)
9.3 Latin America Human Injection Flu Vaccine Market Size by Country
9.3.1 Latin America Human Injection Flu Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Human Injection Flu Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Injection Flu Vaccine Market Size by Type
10.1.1 Middle East and Africa Human Injection Flu Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Human Injection Flu Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Human Injection Flu Vaccine Market Size by Application
10.2.1 Middle East and Africa Human Injection Flu Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Human Injection Flu Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Human Injection Flu Vaccine Market Size by Country
10.3.1 Middle East and Africa Human Injection Flu Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Human Injection Flu Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Human Injection Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Overview
11.2.3 CSL Human Injection Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CSL Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Recent Developments
11.3 GSK
11.3.1 GSK Corporation Information
11.3.2 GSK Overview
11.3.3 GSK Human Injection Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GSK Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GSK Recent Developments
11.4 Viatris
11.4.1 Viatris Corporation Information
11.4.2 Viatris Overview
11.4.3 Viatris Human Injection Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Viatris Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Viatris Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Human Injection Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 AstraZeneca Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Recent Developments
11.6 Hualan Bio
11.6.1 Hualan Bio Corporation Information
11.6.2 Hualan Bio Overview
11.6.3 Hualan Bio Human Injection Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Hualan Bio Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hualan Bio Recent Developments
11.7 Changchun Institute of Biological
11.7.1 Changchun Institute of Biological Corporation Information
11.7.2 Changchun Institute of Biological Overview
11.7.3 Changchun Institute of Biological Human Injection Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Changchun Institute of Biological Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Changchun Institute of Biological Recent Developments
11.8 Sinovac
11.8.1 Sinovac Corporation Information
11.8.2 Sinovac Overview
11.8.3 Sinovac Human Injection Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sinovac Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sinovac Recent Developments
11.9 Jiangsu GDK
11.9.1 Jiangsu GDK Corporation Information
11.9.2 Jiangsu GDK Overview
11.9.3 Jiangsu GDK Human Injection Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Jiangsu GDK Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Jiangsu GDK Recent Developments
11.10 KM Biologics
11.10.1 KM Biologics Corporation Information
11.10.2 KM Biologics Overview
11.10.3 KM Biologics Human Injection Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 KM Biologics Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 KM Biologics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Injection Flu Vaccine Industry Chain Analysis
12.2 Human Injection Flu Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Injection Flu Vaccine Production Mode & Process
12.4 Human Injection Flu Vaccine Sales and Marketing
12.4.1 Human Injection Flu Vaccine Sales Channels
12.4.2 Human Injection Flu Vaccine Distributors
12.5 Human Injection Flu Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Injection Flu Vaccine Industry Trends
13.2 Human Injection Flu Vaccine Market Drivers
13.3 Human Injection Flu Vaccine Market Challenges
13.4 Human Injection Flu Vaccine Market Restraints
14 Key Findings in The Global Human Injection Flu Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Human Injection Flu Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Trivalent Influenza Vaccine
Table 3. Major Manufacturers of Quadrivalent Influenza Vaccine
Table 4. Global Human Injection Flu Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Human Injection Flu Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Human Injection Flu Vaccine Sales by Region (2017-2022) & (Units)
Table 7. Global Human Injection Flu Vaccine Sales Market Share by Region (2017-2022)
Table 8. Global Human Injection Flu Vaccine Sales by Region (2023-2028) & (Units)
Table 9. Global Human Injection Flu Vaccine Sales Market Share by Region (2023-2028)
Table 10. Global Human Injection Flu Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Human Injection Flu Vaccine Revenue Market Share by Region (2017-2022)
Table 12. Global Human Injection Flu Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Human Injection Flu Vaccine Revenue Market Share by Region (2023-2028)
Table 14. Global Human Injection Flu Vaccine Sales by Manufacturers (2017-2022) & (Units)
Table 15. Global Human Injection Flu Vaccine Sales Share by Manufacturers (2017-2022)
Table 16. Global Human Injection Flu Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Human Injection Flu Vaccine Revenue Share by Manufacturers (2017-2022)
Table 18. Human Injection Flu Vaccine Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Human Injection Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Human Injection Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Injection Flu Vaccine as of 2021)
Table 21. Human Injection Flu Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Human Injection Flu Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Human Injection Flu Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Injection Flu Vaccine Sales by Type (2017-2022) & (Units)
Table 26. Global Human Injection Flu Vaccine Sales by Type (2023-2028) & (Units)
Table 27. Global Human Injection Flu Vaccine Sales Share by Type (2017-2022)
Table 28. Global Human Injection Flu Vaccine Sales Share by Type (2023-2028)
Table 29. Global Human Injection Flu Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Human Injection Flu Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Human Injection Flu Vaccine Revenue Share by Type (2017-2022)
Table 32. Global Human Injection Flu Vaccine Revenue Share by Type (2023-2028)
Table 33. Human Injection Flu Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Human Injection Flu Vaccine Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Human Injection Flu Vaccine Sales by Application (2017-2022) & (Units)
Table 36. Global Human Injection Flu Vaccine Sales by Application (2023-2028) & (Units)
Table 37. Global Human Injection Flu Vaccine Sales Share by Application (2017-2022)
Table 38. Global Human Injection Flu Vaccine Sales Share by Application (2023-2028)
Table 39. Global Human Injection Flu Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Human Injection Flu Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Human Injection Flu Vaccine Revenue Share by Application (2017-2022)
Table 42. Global Human Injection Flu Vaccine Revenue Share by Application (2023-2028)
Table 43. Human Injection Flu Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Human Injection Flu Vaccine Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Human Injection Flu Vaccine Sales by Type (2017-2022) & (Units)
Table 46. North America Human Injection Flu Vaccine Sales by Type (2023-2028) & (Units)
Table 47. North America Human Injection Flu Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Human Injection Flu Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Human Injection Flu Vaccine Sales by Application (2017-2022) & (Units)
Table 50. North America Human Injection Flu Vaccine Sales by Application (2023-2028) & (Units)
Table 51. North America Human Injection Flu Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Human Injection Flu Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Human Injection Flu Vaccine Sales by Country (2017-2022) & (Units)
Table 54. North America Human Injection Flu Vaccine Sales by Country (2023-2028) & (Units)
Table 55. North America Human Injection Flu Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Human Injection Flu Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Human Injection Flu Vaccine Sales by Type (2017-2022) & (Units)
Table 58. Europe Human Injection Flu Vaccine Sales by Type (2023-2028) & (Units)
Table 59. Europe Human Injection Flu Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Human Injection Flu Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Human Injection Flu Vaccine Sales by Application (2017-2022) & (Units)
Table 62. Europe Human Injection Flu Vaccine Sales by Application (2023-2028) & (Units)
Table 63. Europe Human Injection Flu Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Human Injection Flu Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Human Injection Flu Vaccine Sales by Country (2017-2022) & (Units)
Table 66. Europe Human Injection Flu Vaccine Sales by Country (2023-2028) & (Units)
Table 67. Europe Human Injection Flu Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Human Injection Flu Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Human Injection Flu Vaccine Sales by Type (2017-2022) & (Units)
Table 70. Asia Pacific Human Injection Flu Vaccine Sales by Type (2023-2028) & (Units)
Table 71. Asia Pacific Human Injection Flu Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Human Injection Flu Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Human Injection Flu Vaccine Sales by Application (2017-2022) & (Units)
Table 74. Asia Pacific Human Injection Flu Vaccine Sales by Application (2023-2028) & (Units)
Table 75. Asia Pacific Human Injection Flu Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Human Injection Flu Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Human Injection Flu Vaccine Sales by Region (2017-2022) & (Units)
Table 78. Asia Pacific Human Injection Flu Vaccine Sales by Region (2023-2028) & (Units)
Table 79. Asia Pacific Human Injection Flu Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Human Injection Flu Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Human Injection Flu Vaccine Sales by Type (2017-2022) & (Units)
Table 82. Latin America Human Injection Flu Vaccine Sales by Type (2023-2028) & (Units)
Table 83. Latin America Human Injection Flu Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Human Injection Flu Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Human Injection Flu Vaccine Sales by Application (2017-2022) & (Units)
Table 86. Latin America Human Injection Flu Vaccine Sales by Application (2023-2028) & (Units)
Table 87. Latin America Human Injection Flu Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Human Injection Flu Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Human Injection Flu Vaccine Sales by Country (2017-2022) & (Units)
Table 90. Latin America Human Injection Flu Vaccine Sales by Country (2023-2028) & (Units)
Table 91. Latin America Human Injection Flu Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Human Injection Flu Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Human Injection Flu Vaccine Sales by Type (2017-2022) & (Units)
Table 94. Middle East and Africa Human Injection Flu Vaccine Sales by Type (2023-2028) & (Units)
Table 95. Middle East and Africa Human Injection Flu Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Human Injection Flu Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Human Injection Flu Vaccine Sales by Application (2017-2022) & (Units)
Table 98. Middle East and Africa Human Injection Flu Vaccine Sales by Application (2023-2028) & (Units)
Table 99. Middle East and Africa Human Injection Flu Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Human Injection Flu Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Human Injection Flu Vaccine Sales by Country (2017-2022) & (Units)
Table 102. Middle East and Africa Human Injection Flu Vaccine Sales by Country (2023-2028) & (Units)
Table 103. Middle East and Africa Human Injection Flu Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Human Injection Flu Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Major Businesses
Table 107. Sanofi Human Injection Flu Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Sanofi Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Sanofi Recent Developments
Table 110. CSL Corporation Information
Table 111. CSL Description and Major Businesses
Table 112. CSL Human Injection Flu Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. CSL Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. CSL Recent Developments
Table 115. GSK Corporation Information
Table 116. GSK Description and Major Businesses
Table 117. GSK Human Injection Flu Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. GSK Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. GSK Recent Developments
Table 120. Viatris Corporation Information
Table 121. Viatris Description and Major Businesses
Table 122. Viatris Human Injection Flu Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Viatris Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Viatris Recent Developments
Table 125. AstraZeneca Corporation Information
Table 126. AstraZeneca Description and Major Businesses
Table 127. AstraZeneca Human Injection Flu Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. AstraZeneca Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. AstraZeneca Recent Developments
Table 130. Hualan Bio Corporation Information
Table 131. Hualan Bio Description and Major Businesses
Table 132. Hualan Bio Human Injection Flu Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Hualan Bio Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Hualan Bio Recent Developments
Table 135. Changchun Institute of Biological Corporation Information
Table 136. Changchun Institute of Biological Description and Major Businesses
Table 137. Changchun Institute of Biological Human Injection Flu Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Changchun Institute of Biological Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Changchun Institute of Biological Recent Developments
Table 140. Sinovac Corporation Information
Table 141. Sinovac Description and Major Businesses
Table 142. Sinovac Human Injection Flu Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Sinovac Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Sinovac Recent Developments
Table 145. Jiangsu GDK Corporation Information
Table 146. Jiangsu GDK Description and Major Businesses
Table 147. Jiangsu GDK Human Injection Flu Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Jiangsu GDK Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Jiangsu GDK Recent Developments
Table 150. KM Biologics Corporation Information
Table 151. KM Biologics Description and Major Businesses
Table 152. KM Biologics Human Injection Flu Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. KM Biologics Human Injection Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. KM Biologics Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Human Injection Flu Vaccine Distributors List
Table 158. Human Injection Flu Vaccine Customers List
Table 159. Human Injection Flu Vaccine Market Trends
Table 160. Human Injection Flu Vaccine Market Drivers
Table 161. Human Injection Flu Vaccine Market Challenges
Table 162. Human Injection Flu Vaccine Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Injection Flu Vaccine Product Picture
Figure 3. Global Human Injection Flu Vaccine Market Share by Type in 2021 & 2028
Figure 3. Trivalent Influenza Vaccine Product Picture
Figure 4. Quadrivalent Influenza Vaccine Product Picture
Figure 5. Global Human Injection Flu Vaccine Market Share by Application in 2021 & 2028
Figure 6. 6 Months to 3 Years
Figure 7. > 3 Years
Figure 8. Human Injection Flu Vaccine Report Years Considered
Figure 9. Global Human Injection Flu Vaccine Sales 2017-2028 (Units)
Figure 10. Global Human Injection Flu Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Human Injection Flu Vaccine Revenue 2017-2028 (US$ Million)
Figure 12. Global Human Injection Flu Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Human Injection Flu Vaccine Sales Market Share by Region (2017-2022)
Figure 14. Global Human Injection Flu Vaccine Sales Market Share by Region (2023-2028)
Figure 15. North America Human Injection Flu Vaccine Sales YoY (2017-2028) & (Units)
Figure 16. North America Human Injection Flu Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Human Injection Flu Vaccine Sales YoY (2017-2028) & (Units)
Figure 18. Europe Human Injection Flu Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Human Injection Flu Vaccine Sales YoY (2017-2028) & (Units)
Figure 20. Asia-Pacific Human Injection Flu Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Human Injection Flu Vaccine Sales YoY (2017-2028) & (Units)
Figure 22. Latin America Human Injection Flu Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Human Injection Flu Vaccine Sales YoY (2017-2028) & (Units)
Figure 24. Middle East & Africa Human Injection Flu Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Human Injection Flu Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Human Injection Flu Vaccine in the World: Market Share by Human Injection Flu Vaccine Revenue in 2021
Figure 27. Global Human Injection Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Human Injection Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 29. Global Human Injection Flu Vaccine Revenue Market Share by Type (2017-2028)
Figure 30. Global Human Injection Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 31. Global Human Injection Flu Vaccine Revenue Market Share by Application (2017-2028)
Figure 32. North America Human Injection Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 33. North America Human Injection Flu Vaccine Revenue Market Share by Type (2017-2028)
Figure 34. North America Human Injection Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 35. North America Human Injection Flu Vaccine Revenue Market Share by Application (2017-2028)
Figure 36. North America Human Injection Flu Vaccine Sales Share by Country (2017-2028)
Figure 37. North America Human Injection Flu Vaccine Revenue Share by Country (2017-2028)
Figure 38. United States Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Human Injection Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 41. Europe Human Injection Flu Vaccine Revenue Market Share by Type (2017-2028)
Figure 42. Europe Human Injection Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 43. Europe Human Injection Flu Vaccine Revenue Market Share by Application (2017-2028)
Figure 44. Europe Human Injection Flu Vaccine Sales Share by Country (2017-2028)
Figure 45. Europe Human Injection Flu Vaccine Revenue Share by Country (2017-2028)
Figure 46. Germany Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 47. France Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Human Injection Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Human Injection Flu Vaccine Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Human Injection Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Human Injection Flu Vaccine Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Human Injection Flu Vaccine Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Human Injection Flu Vaccine Revenue Share by Region (2017-2028)
Figure 57. China Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. India Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Human Injection Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 67. Latin America Human Injection Flu Vaccine Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Human Injection Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 69. Latin America Human Injection Flu Vaccine Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Human Injection Flu Vaccine Sales Share by Country (2017-2028)
Figure 71. Latin America Human Injection Flu Vaccine Revenue Share by Country (2017-2028)
Figure 72. Mexico Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 75. Middle East and Africa Human Injection Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Human Injection Flu Vaccine Revenue Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Human Injection Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Human Injection Flu Vaccine Revenue Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Human Injection Flu Vaccine Sales Share by Country (2017-2028)
Figure 80. Middle East and Africa Human Injection Flu Vaccine Revenue Share by Country (2017-2028)
Figure 81. Turkey Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 82. Saudi Arabia Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 83. UAE Human Injection Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 84. Human Injection Flu Vaccine Value Chain
Figure 85. Human Injection Flu Vaccine Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed

---